The ZUIA Ukimwi Imarisha AFISA (ZUIA) Project

Ideas & Impact › Resources › The ZUIA Ukimwi Imarisha AFISA (ZUIA) Project

ZUIA, a five-year project run in Kenya with financial support from the U.S. Centers for Disease Control and Prevention, gave increased health care and HIV care and treatment support to an especially high-risk group: non-uniformed military (including police, park rangers, and forestry services) and their families.

Explore Related Resources

Search More Resources

Resource

Protecting Lives, Sustaining Progress

Published March 2026

The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.

Topics:

Advocacy,

Children,

Global Health Security,

Health System Strengthening,

HIV,

Maternal and Child Health,

Mothers and Infants,

Women

Journal Articles

Assessing Time Requirements of Two Models of SARS-CoV- 2 Screening and Testing in Routine Healthcare Services in Kenya and Cameroon

Published March 2025

Introduction Incorporating SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) into routine care settings can facilitate efficient case identification and management in low-resource settings. We assessed the time required to complete SARS-CoV-2 screening and Ag-RDT testing in maternal, neonatal and child health (MNCH), HIV and tuberculosis clinics in selected facilities in Kenya and Cameroon. Methods We conducted […]

Countries:

Cameroon,

Kenya

Journal Articles

A Cross-Sectional Study of the Use of Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus-2 in Kenya

Published January 2025

Overview Mass testing with antigen-detecting rapid diagnostic tests (Ag-RDT), including testing of asymptomatic individuals, is expected to improve the identification of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Mass testing was offered at large gatherings to determine the SARS-CoV-2 case detection rate and the acceptance and cost of implementing this community testing strategy. In 49 […]